Rosetta Biosoftware has announced that the Rosetta Syllego™ system has achieved GeneChip-compatible™ status for use with the Affymetrix microarray platform. This compatibility enables research ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories ...
Kits will be configured for use with the GeneChip System 3000Dx v.2. Asuragen is to develop and manufacture RNA Control Kits for Affymetrix for use with its in vitro transcription reagent kits for ...
At first glance, the luminous image rolling across a conference room wall at Affymetrix Inc. looks like mysterious transmissions from an alien race using an intricate language we don't understand. But ...
Affymetrix, Inc. (NASDAQ:AFFX) today announced that it has signed a distribution agreement with Fisher Scientific, Inc., part of Thermo Fisher Scientific, to distribute the GeneAtlas™ System and its ...
NEW YORK (CBS.MW) -- Affymetrix Inc. said Monday the U.S. Food and Drug Administration has approved its GeneChip system 3000Dx, an instrumentation system to analyze in vitro diagnostic microarrays.
Affymetrix, Inc. and DNA Link, Inc., a Korean genomics-based biotechnology company, have signed a Powered by Affymetrix (PbA) Programme agreement in which DNA Link, Inc. obtains a worldwide license to ...
Agencourt Bioscience, a wholly-owned subsidiary of Beckman Coulter (BEC), NuGEN Technologies, and Affymetrix Clinical Services Laboratory announce a collaboration that has yielded a service offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback